- Free from Publisher KCJ Yuen, NR Baker, G Rayman - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—The study was of double-blind, randomized,
placebo-controlled, and two-period cross-over design. After a 2-week run-in
period, 22 diabetic patients (13 men, 20 with type 2 diabetes, age [mean ± ... Cited by 64 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org [PDF] G Rayman, NR Baker, S Krishnan - Diabetes Care, 2003 - Am Diabetes Assoc Although eating disorders are com- mon in late adolescent diabetic pa- tients,
the occurrence in younger populations, particularly male diabetic patients, is
not well documented (1,2). The prevalence was studied in 60 boys and 38 ... Cited by 20 - Related articles - BL Direct - All 5 versions
RL Barbano, DN Herrmann, S Hart-Gouleau, … - Archives of Neurology, 2004 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Background The treatment ... Cited by 83 - Related articles - BL Direct - All 4 versions
SO Oyibo, YDM Prasad, NJ Jackson, EB Jude … - Diabetic Medicine, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 53 - Related articles - BL Direct - All 4 versions
T Sasaki, H Yasuda, K Maeda, R Kikkawa - Neuroreport, 1998 - journals.lww.com TO evaluate the role of nitric oxide synthase (nNOS) in the pathogenesis of
diabetic neuropathy, we investigated nociception and nNOS expression in dorsal
root ganglion (DRG) of rats with streptozocin-induced diabetes. Paw ... Cited by 42 - Related articles - BL Direct - All 3 versions
- ►jiansuo.net [PDF] - Free from Publisher AS Ametov, A Barinov, PJ Dyck, R Hermann, N … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS— Metabolically stable diabetic patients with
symptomatic (stage 2) diabetic sensorimotor polyneuropathy (DSPN) were
randomized to a parallel, double-blind study of ALA (600 mg) (n = 60) or ... Cited by 171 - Related articles - BL Direct - All 7 versions
- Free from Publisher N Hotta, T Toyota, K Matsuoka, Y Shigeta, R … - Diabetes Care, 2001 - cat.inist.fr OBJECTIVE The purpose of this study was to evaluate the efficacy of fidarestat,
a novel aldose reductase BAR) inhibitor, in a double-blind placebo controlled
study in patients with type 1 and type 2 diabetes and associated peripheral ... Cited by 62 - Related articles - BL Direct - All 5 versions
Y Harati, C Gooch, M Swenson, SV Edelman, … - Journal of diabetes and its complications, 2000 - Elsevier Results: A total of 117 patients (56 former tramadol and 61 former placebo)
entered the study. On the first day of the study, patients formerly treated with
placebo had a significantly higher mean pain intensity score (2.2±1.02 vs. ... Cited by 100 - Related articles - BL Direct - All 9 versions
E Eisenberg, Y Lurie, C Braker, D Daoud, A … - Neurology, 2001 - AAN Enterprises Methods:— The authors randomly assigned 59 patients to receive either
lamotrigine (titrated from 25 to 400 mg/day) or placebo over a 6-week period.
Primary outcome measure was self-recording of pain intensity twice daily ... Cited by 205 - Related articles - BL Direct - All 5 versions
P Amin, NDC Sturrock - Diabetic Medicine, 2003 - interscience.wiley.com Methods Seventeen patients with diabetes (nine men) completed this double-blind
randomized crossover placebo-controlled trial of intravenous amantadine. The
average age was 58.4 (sd 11) years, with duration of diabetes of 21.1 (8.7) ... Cited by 26 - Related articles - BL Direct - All 5 versions
